quinazolines has been researched along with n-methylaspartate in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (21.43) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 5 (35.71) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Bleuel, Z; Clifford, MM; Ellis, GJ; Humbel, U; Klingelschmidt, A; Messer, J; Mutel, V; Richards, JG; Trube, G | 1 |
| Almási, J; Kökösi, J; Noszál, B; Takács-Novák, K | 1 |
| Almási, J; Kökösi, J; Takács-Novák, K; Vámos, J | 1 |
| Araie, M; Koide, T; Mizuno, K; Yoshimura, M | 1 |
| Cho, DH; Han, G; Kim, YH; Lee, IK; Yoo, ID; Yun, BS | 1 |
| Choi, JI; Jeong, SW; Yoon, MH | 1 |
| Li, B; Malinow, R; Mei, L; Woo, RS | 1 |
| Catarzi, D; Colotta, V; Costagli, C; Filacchioni, G; Galli, A; Lenzi, O; Varano, F | 1 |
| Hajós, M; Hoffmann, WE; Kiss, T | 1 |
| Amariglio, N; Blatt, I; Chapman, J; Dominissini, D; Itsekson, Z; Maggio, N; Rechavi, G; Tanne, D | 1 |
| Asano, D; Ishii, K; Mori, A; Nakahara, T; Sakamoto, K | 1 |
| Arima, S; Asano, D; Ishii, K; Kondo, R; Mori, A; Nagamitsu, T; Nakahara, T; Nakano, A; Sakamoto, K; Ushikubo, H | 1 |
| Cheng, M; Ma, C; Wang, C; Wang, J; Yang, D; Zhang, L; Zhao, C; Zhao, Y | 1 |
| Arima, S; Mori, A; Morita, A; Nagamitsu, T; Nakahara, T; Sakamoto, K; Yoshizumi, M | 1 |
14 other study(ies) available for quinazolines and n-methylaspartate
| Article | Year |
|---|---|
Binding characteristics of a potent AMPA receptor antagonist [3H]Ro 48-8587 in rat brain.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Anti-Anxiety Agents; Benzodiazepines; Brain Chemistry; Dizocilpine Maleate; Electrophysiology; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Imidazoles; In Situ Hybridization; Kainic Acid; Kinetics; Male; N-Methylaspartate; Quinazolines; Quinoxalines; Radioligand Assay; Rats; Rats, Inbred Strains; Receptors, AMPA; RNA, Messenger; Tritium | 1998 |
Characterization of potential NMDA and cholecystokinin antagonists I. acid-base properties of 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acids at the molecular and submolecular levels.
Topics: Cholecystokinin; Hydrogen-Ion Concentration; N-Methylaspartate; Quinazolines; Spectrophotometry, Ultraviolet | 1999 |
Characterization of potential NMDA and cholecystokinin antagonists. II. Lipophilicity studies on 2-methyl-4-oxo-3H-quinazoline-3-alkyl-carboxylic acid derivatives.
Topics: Cholecystokinin; Chromatography, Thin Layer; N-Methylaspartate; Quinazolines | 1999 |
Neuroprotective effect and intraocular penetration of nipradilol, a beta-blocker with nitric oxide donative action.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Blood-Retinal Barrier; Cell Count; Dose-Response Relationship, Drug; Drug Combinations; Male; N-Methylaspartate; Neuroprotective Agents; Nitric Oxide; Nitric Oxide Donors; Nitroprusside; Propanolamines; Quinazolines; Rabbits; Rats; Rats, Sprague-Dawley; Retina; Retinal Artery; Timolol; Vasoconstriction | 2001 |
Dictyoquinazols A, B, and C, new neuroprotective compounds from the mushroom Dictyophora indusiata.
Topics: Agaricales; Animals; Cells, Cultured; Cerebellar Cortex; Chromatography, High Pressure Liquid; Dose-Response Relationship, Drug; Glutamic Acid; Korea; Mice; Molecular Structure; N-Methylaspartate; Neurons; Neuroprotective Agents; Nuclear Magnetic Resonance, Biomolecular; Quinazolines; Stereoisomerism; Triterpenes | 2002 |
Spinal gabapentin and antinociception: mechanisms of action.
Topics: Acetates; Adrenergic alpha-Antagonists; Adrenergic Antagonists; alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Amines; Analgesics; Animals; Atropine; Cyclohexanecarboxylic Acids; Dihydroergocristine; Enzyme Inhibitors; Excitatory Amino Acid Agonists; GABA Antagonists; Gabapentin; gamma-Aminobutyric Acid; Injections, Spinal; Leucine; Male; Mecamylamine; Muscarinic Antagonists; N-Methylaspartate; Naloxone; Narcotic Antagonists; Nicotinic Antagonists; Pain Measurement; Quinazolines; Rats; Rats, Sprague-Dawley; Serine; Spinal Cord; Thapsigargin; Triazoles | 2003 |
The neuregulin-1 receptor erbB4 controls glutamatergic synapse maturation and plasticity.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Animals; Animals, Newborn; Drug Interactions; Enzyme Inhibitors; ErbB Receptors; Excitatory Postsynaptic Potentials; Glutamic Acid; Hippocampus; In Vitro Techniques; Microscopy, Confocal; N-Methylaspartate; Neuregulin-1; Neuronal Plasticity; Neurons; Patch-Clamp Techniques; Quinazolines; Rats; Receptor, ErbB-4; RNA Interference; RNA, Small Interfering; Synapses; Synaptic Transmission; Transfection; Tyrphostins | 2007 |
Novel AMPA and kainate receptor antagonists containing the pyrazolo[1,5-c]quinazoline ring system: Synthesis and structure-activity relationships.
Topics: alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid; Molecular Structure; N-Methylaspartate; Pyrazoles; Quinazolines; Receptors, Kainic Acid; Structure-Activity Relationship | 2008 |
Delta oscillation and short-term plasticity in the rat medial prefrontal cortex: modelling NMDA hypofunction of schizophrenia.
Topics: Animals; Biphenyl Compounds; Delta Rhythm; Disease Models, Animal; Dizocilpine Maleate; Electric Stimulation; Electroencephalography; Excitatory Postsynaptic Potentials; Hippocampus; Lidocaine; Male; N-Methylaspartate; Neuronal Plasticity; Prefrontal Cortex; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Receptors, N-Methyl-D-Aspartate; Schizophrenia; Sulfonamides; Synaptic Transmission; Time Factors | 2011 |
Thrombin regulation of synaptic plasticity: implications for physiology and pathology.
Topics: Animals; Biophysics; Dose-Response Relationship, Drug; Electric Stimulation; Endothelial Protein C Receptor; Fibrinolysin; Hippocampus; In Vitro Techniques; Long-Term Potentiation; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Neurons; Patch-Clamp Techniques; Phosphopyruvate Hydratase; Pyrroles; Quinazolines; Receptor, PAR-1; Receptors, Cell Surface; Thrombin | 2013 |
Regression of retinal capillaries following N-methyl-D-aspartate-induced neurotoxicity in the neonatal rat retina.
Topics: Age Factors; Animals; Animals, Newborn; Capillaries; Collagen Type IV; Disease Models, Animal; Enzyme Inhibitors; Excitatory Amino Acid Agonists; Gene Expression Regulation, Developmental; Male; N-Methylaspartate; Neurotoxicity Syndromes; Phenylurea Compounds; Plant Lectins; Quinazolines; Rats; Rats, Sprague-Dawley; Rec A Recombinases; Retinal Degeneration; Statistics, Nonparametric; Vascular Endothelial Growth Factor A | 2015 |
Retinal neuronal cell loss prevents abnormal retinal vascular growth in a rat model of retinopathy of prematurity.
Topics: Animals; Capillaries; Cell Proliferation; Disease Models, Animal; N-Methylaspartate; Phenylurea Compounds; Protein Kinase Inhibitors; Quinazolines; Rats; Rats, Sprague-Dawley; Retina; Retinal Ganglion Cells; Retinal Neurons; Retinal Vessels; Retinopathy of Prematurity; Vascular Endothelial Growth Factor A | 2018 |
Design, synthesis and bioevaluation of 1,2,3,9-tetrahydropyrrolo[2,1-b]quinazoline-1-carboxylic acid derivatives as potent neuroprotective agents.
Topics: Calcium; Carboxylic Acids; Cell Line; Drug Design; Humans; MAP Kinase Signaling System; Molecular Docking Simulation; N-Methylaspartate; Neuroprotective Agents; Quinazolines; Receptors, N-Methyl-D-Aspartate; Up-Regulation | 2018 |
Pharmacological depletion of retinal neurons prevents vertical angiogenic sprouting without affecting the superficial vascular plexus.
Topics: Animals; Astrocytes; Female; Male; Mice, Inbred ICR; N-Methylaspartate; Neovascularization, Physiologic; Phenylurea Compounds; Quinazolines; Retina | 2021 |